In the News

Share
1715 News Items found
A scientist works at a computer screen with the MSK logo
MSK and NIH Scientists Develop AI Tool to Predict How Cancer Patients Will Respond to Immunotherapy
In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.
Large letters that say ASCO promoting annual meeting in Chicago.
MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting
Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.
Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.
Rectal Cancer Disappears After Experimental Use of Immunotherapy
Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People
Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
MSK breast medical oncologist Janice Shen.
If You Find a Lump in Your Breast, Here’s What To Do Next
Learn what to do if you find a lump in your breast.
Feature
MSK technician Jennifer Moreta helping give a mammogram.
Common Breast Lumps That Aren’t Cancer
Learn about the different types of benign breast lumps.
An MSK scientist peers through a microscope
MSK Research Highlights, May 24, 2024
New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.
In the Clinic
MSK urologic surgeon Timothy Donahue
New Prostate Cancer Surgery Imaging Technique Could Reduce Side Effects
Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.
GSK master’s degree recipients with members of the platform party
MSK’s 2024 Commencement and Convocation Honors Degree Recipients and Award Winners
At Memorial Sloan Kettering Cancer Center’s 45th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Dr. Michael Overholtzer speaks to students.
Meet the 2024 Graduates of the Gerstner Sloan Kettering Graduate School
Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.